Could influenza transmission be reduced by restricting mass gatherings? Towards an evidence-based policy framework

Journal of Epidemiology and Global Health

Volumn 1, Issue 1, 2011, Pages 33-60

  Ishola, David A ^a,b   Phin, Nick ^a,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CHESTER   (United Kingdom)

Author keywords

Evidence; Influenza; Mass gathering; Policy; Transmission

Indexed keywords

DATA BASE; DATA EXTRACTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; OBSERVATIONAL STUDY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; QUALITY CONTROL; QUASI EXPERIMENTAL STUDY; REVIEW; SOCIAL DISTANCE; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

EID: 84855959123     PISSN: 22106006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jegh.2011.06.004     Document Type: Review

References (57)

1. Brankston G., Gitterman L., Hirji Z., Lemieux C., et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, 7:257-265.
2. Lemieux C, Brankston G, Gitterman L, Hirji Z, et al. Questioning aerosol transmission of influenza. Emerg Infect Dis 2007;13:173-74; author reply 174-75.
3. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009, 6(Suppl. 6):S783-790.
4. Michael J.A., Barbera J.A. Mass gathering medical care: a twenty-five year review. Prehosp Disaster Med 1997, 12:305-312.
5. Milsten A.M., Maguire B.J., Bissell R.A., Seaman K.G. Mass-gathering medical care: a review of the literature. Prehosp Disaster Med 2002, 17:151-162.
6. Zielinski A. Evidence for excessive incidence of infectious diseases at mass gatherings with special reference to sporting events. Przegl Epidemiol 2009, 63:343-351.
7. Jefferson T, Del Mar C, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2010;CD006207.
8. Aledort J.E., Lurie N., Wasserman J., Bozzette S.A. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health 2007, 7:208.
9. Centre for Reviews and Dissemination, University of York. CRD's guidance for undertaking reviews in health care. York: University of York; 2009. Available from: (Accessed 02.10.10). http://www.york.ac.uk/inst/crd/guidance.htm.
10. Harris A.D., McGregor J.C., Perencevich E.N., Furuno J.P., et al. The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc 2006, 13:16-23.
11. Rothman K.J., Greenland S., Lash T.L. Types of epidemiologic studies. Modern epidemiology 2008, 87-99. Lippincott Williams & Wilkins, Philadelphia. 3rd ed. K.J. Rothman, S. Greenland, T.L. Lash (Eds.).
12. Critical Appraisal Skills Programme Tools. Critical Appraisal Skills Programme, Public Health Resource Unit, Oxford. Available from: (accessed 29.10.10). http://www.sph.nhs.uk/what-we-do/public-health-workforce/resources/critical-appraisals-skills-programme.
13. ORION Statement and tools. URL: Available from: (Accessed 29.10.10). http://www.idrn.org/orion.php.
14. Stone S.P., Cooper B.S., Kibbler C.C., Cookson B.D., et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007, 7:282-288.
15. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
16. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., et al. The P.R.I.S.M.A. statement for reporting systematic reviews, meta-analyses of studies that evaluate health care interventions: explanation, elaboration. PLoS Med 2009, 6:e1000100.
17. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
18. Qureshi H., Gessner B.D., Leboulleux D., Hasan H., et al. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine 2000, 18:2956-2962.
19. Choudhry A.J., Al-Mudaimegh K.S., Turkistani A.M., Al-Hamdan N.A. Hajj-associated acute respiratory infection among Hajjis from Riyadh. East Mediterr Health J 2006, 12:300-309.
20. Deris Z.Z., Hasan H., Sulaiman S.A., Wahab M.S., et al. The prevalence of acute respiratory symptoms and role of protective measures among Malaysian Hajj pilgrims. J Travel Med 2010, 17:82-88.
21. Gautret P., Soula G., Delmont J., Parola P., et al. Common health hazards in French pilgrims during the Hajj of 2007: a prospective cohort study. J Travel Med 2009, 16:377-381.
22. Gautret P., Yong W., Soula G., Gaudart J., et al. Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. Clin Microbiol Infect 2009, 15:335-340.
23. Rashid H, Shafi S, Booy R, El Bashir H, Ali K, Zambon MC, et al. Emerg Health Threats J 2008;1:e2. doi:10.3134/ehtj.08.002. Available from: (accessed 15.10.2010). http://www.eht-forum.org/ehtj/journal/v1/pdf/ehtj080022a.pdf.
24. Balkhy H.H., Memish Z.A., Bafaqeer S., Almuneef M.A. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med 2004, 11:82-86.
25. El Bashir H., Haworth E., Zambon M., Shafi S., et al. Influenza among U.K. pilgrims to Hajj, 2003. Emerg Infect Dis 2004, 10:1882-1883.
26. Gautret P., Vu Hai V., Sani S., Doutchi M., et al. Protective measures against acute respiratory symptoms in French pilgrims participating in the Hajj of 2009. J Travel Med 2011, 18:53-55.
27. Rashid H., Shafi S., Haworth E., El Bashir H., et al. Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims. Clin Microbiol Infect 2008, 14:569-574.
28. Blyth C.C., Foo H., van Hal S.J., Hurt A.C., et al. Influenza outbreaks during World Youth Day 2008 mass gathering. Emerg Infect Dis 2010, 16:809-815.
29. Botelho-Nevers E., Gautret P., Benarous L., Charrel R., et al. Travel-related influenza A/H1N1 infection at a rock festival in Hungary: one virus may hide another one. J Travel Med 2010, 17:197-198.
30. Gutierrez I., Litzroth A., Hammadi S., Van Oyen H., et al. Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July. Euro Surveill 2009, 2009:14.
31. Loncarevic G., Payne L., Kon P., Petrovic V., et al. Public health preparedness for two mass gathering events in the context of pandemic influenza (H1N1) 2009 - Serbia, July. Euro Surveill 2009, 2009:14.
32. Pang X., Zhu Z., Xu F., Guo J., et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA 2003, 290:3215-3221.
33. Saenz A.C., Assaad F.A., Cockburn W.C. Outbreak of A2-Hong Kong-68 influenza at an international medical conference. Lancet 1969, 1:91-93.
34. Zepeda-Lopez H.M., Perea-Araujo L., Miliar-Garcia A., Dominguez-Lopez A., et al. Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico. PLoS One 2010, 5:e13256.
35. Aimone F. The 1918 influenza epidemic in New York City: a review of the public health response. Public Health Rep 2010, 125(Suppl. 3):71-79.
36. Hatchett R.J., Mecher C.E., Lipsitch M. Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci USA 2007, 104:7582-7587.
37. Markel H., Lipman H.B., Navarro J.A., Sloan A., et al. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA 2007, 298:644-654.
38. Gundlapalli A.V., Rubin M.A., Samore M.H., Lopansri B., et al. Influenza, Winter Olympiad, 2002. Emerg Infect Dis 2006, 12:144-146.
39. Lim H.C., Cutter J., Lim W.K., Ee A., et al. The influenza A (H1N1-2009) experience at the inaugural Asian Youth Games Singapore 2009: mass gathering during a developing pandemic. Br J Sports Med 2010, 44:528-532.
40. Schenkel K., Williams C., Eckmanns T., Poggensee G., et al. Enhanced surveillance of infectious diseases: the 2006 FIFA World Cup experience, Germany. Euro Surveill 2006, 11:234-238.
41. Demicheli V, Raso R, Tiberti D, Barale A, et al. Results from the integrated surveillance system for the 2006 Winter Olympic and Paralympic Games in Italy. Euro Surveill 2006; 11: E060817 060815.
42. World Health Organisation. Communicable disease alert and response for mass gatherings: key considerations, June 2008.
43. Ahmed Q.A., Arabi Y.M., Memish Z.A. Health risks at the Hajj. Lancet 2006, 367:1008-1015.
44. Haworth E., Rashid H., Booy R. Prevention of pandemic influenza after mass gatherings - learning from Hajj. J R Soc Med 2010, 103:79-80.
45. Memish Z.A., McNabb S.J., Mahoney F., Alrabiah F., et al. Establishment of public health security in Saudi Arabia for the 2009 Hajj in response to pandemic influenza A H1N1. Lancet 2009, 374:1786-1791.
46. Rashid H., Haworth E., Shafi S., Memish Z.A., et al. Pandemic influenza: mass gatherings and mass infection. Lancet Infect Dis 2008, 8:526-527.
47. Thackway S., Churches T., Fizzell J., Muscatello D., et al. Should cities hosting mass gatherings invest in public health surveillance, planning? Reflections from a decade of mass gatherings in Sydney, Australia. BMC Public Health 2009, 9:324.
48. Human infection with new influenza A (H1N1) virus: WHO Consultation on suspension of classes and restriction of mass gatherings to mitigate the impact of epidemics caused by influenza A (H1N1), May 2009. Wkly Epidemiol Rec 2009;84:269-71.
49. Baum N.M., Jacobson P.D., Goold S.D. Listen to the people: public deliberation about social distancing measures in a pandemic. Am J Bioeth 2009, 9:4-14.
50. Eastwood K., Durrheim D.N., Butler M., Jon A. Responses to pandemic (H1N1) 2009, Australia. Emerg Infect Dis 2010, 16:1211-1216.
51. Ferguson N., Nicoll A., Schwartz B. SIP 5: Social distancing during a pandemic. Not sexy, but sometimes effective: social distancing and non-pharmaceutical interventions. Vaccine 2009, 27:6383-6386.
52. Gostin L.O. Influenza A(H1N1) and pandemic preparedness under the rule of international law. JAMA 2009, 301:2376-2378.
53. Gostin L.O., Bayer R., Fairchild A.L. Ethical and legal challenges posed by severe acute respiratory syndrome: implications for the control of severe infectious disease threats. JAMA 2003, 290:3229-3237.
54. Kozlowski L.T., Kiviniemi M.T., Ram P.K. Easier said than done: behavioral conflicts in following social-distancing recommendations for influenza prevention. Public Health Rep 2010, 125:789-792.
55. Liao Q., Cowling B., Lam W.T., Ng M.W., et al. Situational awareness, health protective responses to pandemic influenza A (H1N1) in Hong Kong: a cross-sectional study. PLoS One 2010, 5:e13350.
56. Braunack-Mayer A.J., Street J.M., Rogers W.A., Givney R., et al. Including the public in pandemic planning: a deliberative approach. BMC Public Health 2010, 10:501.
57. Jefferson T., Del Mar C., Dooley L., Ferroni E., et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009, 339:b3675.